Deli Liu

1.9k total citations
35 papers, 1.2k citations indexed

About

Deli Liu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Deli Liu has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Deli Liu's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Deli Liu is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Deli Liu collaborates with scholars based in United States, China and Israel. Deli Liu's co-authors include Andrea Sboner, Christopher E. Barbieri, Mark A. Rubin, Cody Ashby, Guojun Li, Carole L. Cramer, Juntao Liu, Zheng Chang, Xiuzhen Huang and Yu Zhang and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Deli Liu

35 papers receiving 1.2k citations

Peers

Countries citing papers authored by Deli Liu

Since Specialization

Citations

This map shows the geographic impact of Deli Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deli Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deli Liu more than expected).

Fields of papers citing papers by Deli Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deli Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deli Liu. The network helps show where Deli Liu may publish in the future.

Co-authorship network of co-authors of Deli Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Deli Liu. A scholar is included among the top collaborators of Deli Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deli Liu. Deli Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC). 2024 ·Journal of Clinical Oncology ·Sherene Loi, Stephen Johnston, Carlos L. Arteaga, Stephanie L. Graff, Sarat Chandarlapaty, Matthew P. Goetz, Christine Desmedt, Hironobu Sasano, Deli Liu, Vanessa Rodrik-Outmezguine, Anthony Sireci, (unknown), Helen Won, Lacey M. Litchfield, Nicholas C. Turner	12
2	Canonical androgen response element motifs are tumor suppressive regulatory elements in the prostate 2024 ·Nature Communications ·Xuanrong Chen, Michael A. Augello, Deli Liu, Kevin Lin, (unknown), Martin Sjöström, Francesca Khani, Lesa D. Deonarine, Yang Liu, (unknown), Jian Wu, (unknown), (unknown), Massimo Loda, Felix Y. Feng, Brian D. Robinson, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	6
3	Abstract GS03-06: Genomic and transcriptomic profiling of primary tumors from patients with HR+, HER2-, node-positive, high-risk early breast cancer in the monarchE trial 2024 ·Cancer Research ·Nicholas C. Turner, Jorge S. Reis‐Filho, Matthew P. Goetz, Christine Desmedt, Sarat Chandarlapaty, Hironobu Sasano, Carlos L. Arteaga, Sherene Loi, Stephanie L. Graff, Deli Liu, Vanessa Rodrik-Outmezguine, Anthony Sireci, (unknown), Helen Won, Lacey M. Litchfield, (unknown), Stephen Johnston	5
4	Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130 2022 ·Oncogene ·Oh‐Joon Kwon, Boyu Zhang, Deyong Jia, Li Zhang, Xing Wei, Zhicheng Zhou, Deli Liu, (unknown), Kai Zhang, (unknown), Paul Labhart, Andrea Sboner, (unknown), Michael C. Haffner, Chad J. Creighton, Xin Li	7
5	Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer 2021 ·Journal of Clinical Investigation ·Deli Liu, Michael A. Augello, Ivana Grbeša, Davide Prandi, Yang Liu, Jonathan E. Shoag, R. Jeffrey Karnes, Bruce J. Trock, Eric A. Klein, Robert B. Den, Francesca Demichelis, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	27
6	G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer 2021 ·Nature Communications ·(unknown), Chenyi Yang, Limei Xu, Deli Liu, Yu Wang, Dennis Huang, Lesa D. Deonarine, Joanna Cyrta, Elai Davicioni, Andrea Sboner, Brian D. Robinson, Arul M. Chinnaiyan, Mark A. Rubin, Christopher E. Barbieri, Pengbo Zhou	27
7	Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity 2021 ·Cell Reports ·Ivana Grbeša, Michael A. Augello, Deli Liu, Dylan McNally, Christopher Gaffney, Dennis Huang, Kevin Lin, (unknown), Ramy Goueli, Brian D. Robinson, Francesca Khani, Lesa D. Deonarine, Mirjam Blattner, Olivier Elemento, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri	23
8	Tumor size and genomic risk in localized prostate cancer 2021 ·Urologic Oncology Seminars and Original Investigations ·Christopher Gaffney, Deli Liu, Victoria Cooley, (unknown), (unknown), Brian D. Robinson, Francesca Khani, Peter Y. Cai, Simpa S. Salami, (unknown), Jonathan E. Shoag, Christopher E. Barbieri	2
9	Colorimetric determination of DNA using an aptamer and plasmonic nanoplatform 2020 ·Microchimica Acta ·Fuming Sang, (unknown), Jianxin Pan, Deli Liu, Zhizhou Zhang	2
10	Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes 2020 ·European Urology Open Science ·Salma Ben‐Salem, Qiang Hu, Yang Liu, Mohammed Alshalalfa, (unknown), Irène Wang, Varadha Balaji Venkadakrishnan, Dhirodatta Senapati, Sangeeta Kumari, Deli Liu, Andrea Sboner, Christopher E. Barbieri, Felix Y. Feng, Jean-Noël Billaud, Elai Davicioni, Song Liu, Hannelore V. Heemers	5
11	Prognostic value of the SPOP mutant genomic subclass in prostate cancer 2020 ·Urologic Oncology Seminars and Original Investigations ·Jonathan Shoag, Deli Liu, Xiaoyue Ma, Clara Oromendia, Paul J. Christos, Karla V. Ballman, (unknown), Peter Y. Cai, Christopher Gaffney, Eric A. Klein, Jeffrey Karnes, Robert B. Den, Yang Liu, Elai Davicioni, Christopher E. Barbieri	8
12	SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG 2017 ·Journal of Clinical Investigation ·Jonathan Shoag, Deli Liu, Mirjam Blattner, Andrea Sboner, Kyung Park, Lesa D. Deonarine, Brian D. Robinson, Juan Miguel Mosquera, Yu Chen, Mark A. Rubin, Christopher E. Barbieri	22
13	SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling 2017 ·Cancer Cell ·Mirjam Blattner, Deli Liu, Brian D. Robinson, Dennis Huang, Anton Poliakov, Dong Gao, Srilakshmi Nataraj, Lesa D. Deonarine, Michael A. Augello, Verena Sailer, Lalit Ponnala, Michael Ittmann, Arul M. Chinnaiyan, Andrea Sboner, Yu Chen, Mark A. Rubin, Christopher E. Barbieri	140
14	Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition 2017 ·European Urology ·Aditya Dutta, Sukanya Panja, Renu K. Virk, (unknown), (unknown), Serge Cremers, David Golombos, Deli Liu, Juan Miguel Mosquera, Elahe A. Mostaghel, Christopher E. Barbieri, Antonina Mitrofanova, Cory Abate‐Shen	13
15	Bridger: a new framework for de novo transcriptome assembly using RNA-seq data 2015 ·Genome Biology ·Zheng Chang, Guojun Li, Juntao Liu, Yu Zhang, Cody Ashby, Deli Liu, Carole L. Cramer, Xiuzhen Huang	202
16	Canine Spontaneous Head and Neck Squamous Cell Carcinomas Represent Their Human Counterparts at the Molecular Level 2015 ·PLoS Genetics ·Deli Liu, Huan Xiong, Angela E. Ellis, Nicole C. Northrup, Kevin K. Dobbin, Dong M. Shin, Shaying Zhao	41
17	SPOP mutation leads to genomic instability in prostate cancer 2015 ·eLife ·Gunther Boysen, Christopher E. Barbieri, Davide Prandi, Mirjam Blattner, Sung‐Suk Chae, (unknown), Srilakshmi Nataraj, Dennis Huang, Clarisse Marotz, Limei Xu, Julie Huang, Paola Lecca, Sagar Chhangawala, Deli Liu, Pengbo Zhou, Andrea Sboner, Johann S. de Bono, Francesca Demichelis, Yariv Houvras, Mark A. Rubin	132
18	Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer 2014 ·Cancer Research ·Deli Liu, Huan Xiong, Angela E. Ellis, Nicole C. Northrup, Carlos O. Rodriguez, Ruth O’Regan, Stephen Dalton, Shaying Zhao	101
19	Reconstructed Adeno-Associated Virus with the Extracellular Domain of Murine PD-1 Induces Antitumor Immunity 2012 ·Asian Pacific Journal of Cancer Prevention ·(unknown), (unknown), Wenying Zhang, Li Xiong, Yongze Yuan, (unknown), Deli Liu, Yingle Liu, Hui Geng	50
20	Construction and function of recombinant AcMNPV with double copies of v-cath gene 2002 ·Chinese Science Bulletin ·Deli Liu	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact